Biotech / Pharma
Oncoswitch
Biotech / Pharma
OncoSwitch Therapeutics, founded by Johns Hopkins researchers, developed a biodegradable nanoparticle designed to improve delivery of mRNA-based cancer vaccines.
Founded
Region
Investors
People